Chulin Sha

Chulin Sha

Imperial College London

H-index: 8

Europe-United Kingdom

About Chulin Sha

Chulin Sha, With an exceptional h-index of 8 and a recent h-index of 8 (since 2020), a distinguished researcher at Imperial College London, specializes in the field of bioinformatics, big data, cancer genetics, system biology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Comparison of MHG and DZsig reveals shared biology and a core overlap group with inferior prognosis in DLBCL

Differential efficacy from the addition of bortezomib to R-CHOP in diffuse large B-cell lymphoma according to the molecular subgroup in the REMoDL-B study with a 5-year follow-up

Longitudinal expression profiling identifies a poor risk subset of patients with ABC-type diffuse large B-cell lymphoma

Five-year survival results from the remodl-B trial (ISRCTN 51837425) show improved outcomes in diffuse large B-cell lymphoma molecular subgroups from the addition of bortezomib …

Resolving heterogeneity in Diffuse Large B-cell Lymphoma using a comprehensive modular expression map

Comparative analysis of gene expression platforms for cell‐of‐origin classification of diffuse large B‐cell lymphoma shows high concordance

Distinct genetic changes reveal evolutionary history and heterogeneous molecular grade of DLBCL with MYC/BCL2 double-hit

Chulin Sha Information

University

Position

___

Citations(all)

646

Citations(since 2020)

628

Cited By

215

hIndex(all)

8

hIndex(since 2020)

8

i10Index(all)

7

i10Index(since 2020)

7

Email

University Profile Page

Google Scholar

Chulin Sha Skills & Research Interests

bioinformatics

big data

cancer genetics

system biology

Top articles of Chulin Sha

Comparison of MHG and DZsig reveals shared biology and a core overlap group with inferior prognosis in DLBCL

Blood Advances

2023/10/24

Differential efficacy from the addition of bortezomib to R-CHOP in diffuse large B-cell lymphoma according to the molecular subgroup in the REMoDL-B study with a 5-year follow-up

Journal of Clinical Oncology

2023/5/5

Longitudinal expression profiling identifies a poor risk subset of patients with ABC-type diffuse large B-cell lymphoma

Blood Advances

2023/3/14

Five-year survival results from the remodl-B trial (ISRCTN 51837425) show improved outcomes in diffuse large B-cell lymphoma molecular subgroups from the addition of bortezomib …

Blood

2022/11/15

Resolving heterogeneity in Diffuse Large B-cell Lymphoma using a comprehensive modular expression map

medRxiv

2022/5/25

Comparative analysis of gene expression platforms for cell‐of‐origin classification of diffuse large B‐cell lymphoma shows high concordance

British Journal of Haematology

2021/2

See List of Professors in Chulin Sha University(Imperial College London)

Co-Authors

academic-engine